Mar. 23 -- WEDNESDAY, Aug. 15 (HealthDay News) -- For the first time, scientists say they have identified an immune molecule that may predict prostate cancer recurrence after surgery. "We discovered a ...
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback